N-((6R,9R,12R,15R,18R,21R)-1,26-diamino-6-carbamoyl-9,12,15,18-tetrakis(3-guanidinopropyl)-1,26-diimino-8,11,14,17,20-pentaoxo-2,7,10,13,16,19,25-heptaazahexacosan-21-yl)-6-(2-(isoquinoline-5-sulfonamido)ethylamino)hexanamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View N-((6R,9R,12R,15R,18R,21R)-1,26-diamino-6-carbamoyl-9,12,15,18-tetrakis(3-guanidinopropyl)-1,26-diimino-8,11,14,17,20-pentaoxo-2,7,10,13,16,19,25-heptaazahexacosan-21-yl)-6-(2-(isoquinoline-5-sulfonamido)ethylamino)hexanamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
N-((6R,9R,12R,15R,18R,21R)-1,26-diamino-6-carbamoyl-9,12,15,18-tetrakis(3-guanidinopropyl)-1,26-diimino-8,11,14,17,20-pentaoxo-2,7,10,13,16,19,25-heptaazahexacosan-21-yl)-6-(2-(isoquinoline-5-sulfonamido)ethylamino)hexanamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Ribosomal protein S6 kinase alpha-5 Protein (Entity type)	Kd
N-((6R,9R,12R,15R,18R,21R)-1,26-diamino-6-carbamoyl-9,12,15,18-tetrakis(3-guanidinopropyl)-1,26-diimino-8,11,14,17,20-pentaoxo-2,7,10,13,16,19,25-heptaazahexacosan-21-yl)-6-(2-(isoquinoline-5-sulfonamido)ethylamino)hexanamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	cGMP-dependent protein kinase 1 Protein (Entity type)	Kd
N-((6R,9R,12R,15R,18R,21R)-1,26-diamino-6-carbamoyl-9,12,15,18-tetrakis(3-guanidinopropyl)-1,26-diimino-8,11,14,17,20-pentaoxo-2,7,10,13,16,19,25-heptaazahexacosan-21-yl)-6-(2-(isoquinoline-5-sulfonamido)ethylamino)hexanamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Ribosomal protein S6 kinase beta-1 Protein (Entity type)	IC50
N-((6R,9R,12R,15R,18R,21R)-1,26-diamino-6-carbamoyl-9,12,15,18-tetrakis(3-guanidinopropyl)-1,26-diimino-8,11,14,17,20-pentaoxo-2,7,10,13,16,19,25-heptaazahexacosan-21-yl)-6-(2-(isoquinoline-5-sulfonamido)ethylamino)hexanamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Rho-associated protein kinase 2 Protein (Entity type)	IC50